Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
China Pharmacy ; (12): 1126-1130, 2023.
Article in Chinese | WPRIM | ID: wpr-972959

ABSTRACT

OBJECTIVE To understand the polypharmacy burden and influencing factors of elderly tuberculosis (TB) in Guizhou province, and to provide reference for reducing the polypharmacy burden of patients. METHODS From April to July 2022, 405 elderly TB outpatients were selected from three designated TB hospitals in Guiyang City, Bijie City, and Qiandongnan Miao and Dong Autonomous Prefecture of Guizhou Province by convenience sampling method as investigation objects. The general situation questionnaire and the Living with Medicines Questionnaire (LMQ) were used for face-to-face survey. Descriptive analysis, one-way ANOVA and multivariate linear regression analysis were used to understand the score of polypharmacy burden of elderly TB patients and explore the factors effecting polypharmacy burden in TB patients. RESULTS The total polypharmacy burden score of 405 elderly TB patients was (112.65±14.59) points, which was higher than the threshold (110 points) for high burden standard in LMQ. Multivariate linear regression analysis showed that aged 80 to 92 years, self-financed+medical insurance, retreatment, drug resistance, and adverse drug reactions were the risk factors for polypharmacy burden in elderly TB patients (P<0.05); living in the city, family member management, volunteer management and intelligent tool-assisted management were the protective factors (P<0.05). CONCLUSIONS The burden of polypharmacy in elderly TB patients from Guizhou province is heavy, and is influenced by patient’s age, residence, payment method, treatment classification, drug resistance, adverse drug reactions, and medication management. It is recommended that medical staff should provide key populations with medication guidance based on influential factor for polypharmacy burden so as to reduce their polypharmacy burden.

2.
Chinese Journal of Practical Nursing ; (36): 906-910, 2022.
Article in Chinese | WPRIM | ID: wpr-930718

ABSTRACT

Objective:To explore the current status and influencing factors of polypharmacy burden in inpatient with elderly comorbidity.Methods:Convenience sampling method was used to select 393 in patients with elderly comorbidity of multiple medications who were hospitalized in North China University of Science and Technology Affiliated Hospital from September 2020 to January 2021 as the research object, using the general situation questionnaire, the Living with Medicines Questionnaire (LMQ), the Perceived Social Support Scale (PSSS), the Medication Compliance Scale (Morisky Scale) to investigate. Descriptive analysis of general data characteristics and polypharmacy burden scores were performed, and t-test, variance analysis, and multiple linear stepwise regression analysis were used to analyze influencing factors. Results:The polypharmacy burden for inpatient with elderly comorbidity was (136.95 ± 22.34) points, and the score rate was 70.23%, which was at a moderately high level. Multi-factor analysis showed that age, education level, personal monthly income, the number of illnesses, the number of medications, the duration of medication, social support, and medication compliance were independent factors influencing polypharmacy burden in inpatient with elderly comorbidity ( R 2=0.821, adjusted R 2=0.818, F=220.65, P<0.001). Conclusions:The polypharmacy burden in inpatient with elderly comorbidity is at a moderately high level. It is recommended that medical staff should develop individualized nursing interventions to reduce the polypharmacy burden for the factors that affect the burden of multiple medications for this population.

SELECTION OF CITATIONS
SEARCH DETAIL